05 July 2021: EditorialDinah V. Parums *
Med Sci Monit 2021; 27:e933831
ABSTRACT: During the global COVID-19 pandemic, data from clinical studies, systematic review, and population registry data have shown that when compared with non-pregnant women, SARS-CoV-2 infection in pregnancy is associated with a small increase in risk to the mother. Large cohort studies and registry data collected from 2020 have included the US Surveillance for Emerging Threats to Mothers and Babies Network (SET-NET), COVI-PREG, the UK and Global Pregnancy and Neonatal Outcomes in COVID-19 (PAN-COVID) study, the American Academy of Pediatrics (AAP) Section on Neonatal-Perinatal Medicine (SONPM) National Perinatal COVID-19 Registry, the Swedish Pregnancy Register, and the Canadian Surveillance of COVID-19 in Pregnancy (CANCOVID-Preg) registry. Recently published data have shown that most maternal infections with SARS-CoV-2 occur during the third trimester and result in a small increase in hospital admission, admission to the intensive care unit (ICU), mechanical ventilation, preterm birth, and increased cesarean sections in mothers infected with SARS-CoV-2. However, currently approved vaccines given in pregnancy result in an immune response to current SARS-CoV-2 variants. Transplacental transmission of SARS-CoV-2 to the fetus can occur, but the immediate and long-term effects on the newborn infant remain unclear. Therefore, women who are pregnant or planning a pregnancy should be managed according to current clinical guidelines with timely vaccination to prevent infection with SARS-CoV-2. This Editorial summarizes what is currently known about maternal SARS-CoV-2 infection and pregnancy outcomes from multinational studies.
Keywords: Editorial, COVID-19, Treatment Outcome
Data from clinical studies, systematic review, and population registry data have shown a small increase in risk to the mother from SARS-CoV-2 infection. Transplacental transmission of SARS-CoV-2 from the mother to the fetus can occur, but the immediate and long-term effects on the newborn infant remain unclear. The increased risk of hospitalization and ICU admission in pregnant women infected with SARS-CoV-2 may be due to the immunosuppressive effects of pregnancy or increased caution by healthcare providers during the COVID-19 pandemic. Women who are pregnant or planning a pregnancy should be managed according to current clinical guidelines with timely vaccination to prevent infection with SARS-CoV-2.
1. Khalil A, Kalafat E, Benlioglu C: SARS-CoV-2 infection in pregnancy: A systematic review and meta-analysis of clinical features and pregnancy outcomes: EClinicalMedicine, 2020; 25; 100446
2. Facchetti F, Bugatti M, Drera E: SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta: EBioMedicine, 2020; 59; 102951
3. Vivanti AJ, Vauloup-Fellous C, Prevot S: Transplacental transmission of SARS-CoV-2 infection: Nat Commun, 2020; 11; 3572
4. Villar J, Ariff S, Gunier RB: Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: The INTERCOVID Multinational Cohort Study: JAMA Pediatr, 2021; 22; e211050
5. Mark EG, McAleese S, Golden WC: Coronavirus disease 2019 in pregnancy and outcomes among pregnant women and neonates: A literature review: Pediatr Infect Dis J, 2021; 40(5); 473-78
6. Parums DV: Editorial: Registries and population databases in clinical research and practice: Med Sci Monit, 2021; 27; e933554
7. Woodworth KR, Olsen EO, Neelam V: Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy-SET-NET, 16 Jurisdictions, March 29–October 14, 2020: MMWR Morb Mortal Wkly Rep, 2020; 69(44); 1635-40
8. Panchaud A, Favre G, Pomar L: An international registry for emergent pathogens and pregnancy: Lancet, 2020; 395(10235); 1483-84
9. Panchaud A, Favre G, Pomar L:: Pregnancy and COVID-19 associated coagulopathy registry (COV-PREG-COAG)
10. Banerjee J, Mullins E, Townson J: Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention: BMJ Open, 2021; 11; e041247
11. Mullins E, Hudak ML, Banerjee J: Pregnancy and neonatal outcomes of COVID-19: Co-reporting of common outcomes from PAN-COVID and AAP-SONPM registries: Ultrasound Obstet Gynecol, 2021; 57(4); 573-81
12. Norman M, Navér L, Söderling J: Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes: JAMA, 2021; 325(20); 2076-86
13. Money D: Canadian surveillance of COVID-19 in pregnancy: Epidemiology, maternal and infant outcomes: Report #4: Released June 3rd, 2021. Maternal and infant outcomes (March 1, 2020 to March 31, 2021) from five Canadian provinces
14. McClymont E, Abenhaim H, Albert A: Canadian surveillance of COVID-19 in pregnancy (CANCOVID-Preg): A rapidly coordinated national response using established regional infrastructures: J Obstet Gynaecol Can, 2021; 43(2); 165-66
15. Parums DV: Editorial: Revised World Health Organization (WHO) terminology for variants of concern and variants of interest of SARS-CoV-2: Med Sci Monit, 2021; 27; e933622
16. Krause PR, Fleming TR, Longini IM: SARS-CoV-2 variants and vaccines: N Engl J Med, 2021; [Epub ahead of print]
17. Collier AY, McMahan K, Yu J: Immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women: JAMA, 2021; 325(23); 2370-80
22 September 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic M...
Med Sci Monit In Press; DOI: 10.12659/MSM.934854
08 September 2021 : Clinical ResearchAcceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...
Med Sci Monit In Press; DOI: 10.12659/MSM.932788
16 July 2021 : Review articleSilent Hypoxemia in Patients with COVID-19 Pneumonia: A Review
Med Sci Monit In Press; DOI: 10.12659/MSM.930776
23 Sep 2021 : Animal ResearchForkhead Box Protein M1 Promotes Nasopharyngeal Carcinoma Cell Tumorigenesis Possibly via the Wnt/β-Catenin...
Med Sci Monit In Press; DOI: 10.12659/MSM.931970
22 Sep 2021 : EditorialEditorial: Global Regulatory Initiatives Deliver Accelerated Approval of the First Bispecific Therapeutic M...
Med Sci Monit In Press; DOI: 10.12659/MSM.934854
22 Sep 2021 : Clinical ResearchA Comparative Study of the Clinical Efficacy and Safety of Pneumatic Trabeculoplasty and Selective Laser Tr...
Med Sci Monit In Press; DOI: 10.12659/MSM.933454
20 Mar 2020 : Clinical ResearchSocial Capital and Sleep Quality in Individuals Who Self-Isolated for 14 Days During the Coronavirus Diseas...
Med Sci Monit 2020; 26:e923921
15 Apr 2020 : Clinical ResearchPsychological Impact and Coping Strategies of Frontline Medical Staff in Hunan Between January and March 20...
Med Sci Monit 2020; 26:e924171
05 May 2020 : Review articleAn Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development
Med Sci Monit 2020; 26:e924700